- Tumor necrosis factor alpha inhibitors or interleukin 17 inhibitors in the treatment of patients with axial spondyloarthritis2019 | First Faculty of Medicine
- Is universal screening for hepatitis C infection prior to commencing antitumour necrosis factor-α therapy necessary?2014 | Faculty of Medicine in Pilsen
- Dissecting cellulitis of the scalp treated with tumour necrosis factor-α inhibitors: experience with two agents2016 | Faculty of Medicine in Pilsen
- Tumor necrosis factor alpha (TNFα) inhibitors in the treatment of severe forms of psoriasis2017 | Third Faculty of Medicine
- Adalimumab in rheumatologic diagnoses2018 | First Faculty of Medicine
- Hidradenitis suppurativa, neutrophilic dermatoses and autoinflammation: what's the link?2016 | Faculty of Medicine in Pilsen
- Present and future of biological therapies for rheumatoid arthritis - a dilemma of choice +12015 | Publication without faculty affiliation
- Hyrimoz - new biosimilars in treatment of rheumatoid arthritis2019 | Second Faculty of Medicine
- Mají inhibitory TNF stále místo v první linii léčby revmatoidní artritidy?2021 | First Faculty of Medicine
- A dissimilar biosimilar? Lichenoid drug eruption induced by an infliximab biosimilar2018 | Faculty of Medicine in Pilsen
- Selected case reports from the tofacitinib clinical program2019 | First Faculty of Medicine
- What we can do for a patient with psoriatic arthritis when TNF inhibitors fail2019 | First Faculty of Medicine
- Advances in treatment of juvenile idiopathic arthritis associated uveitis2021 | Publication without faculty affiliation